Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Somil Mehta of Sharekhan has recommended selling Cipla.
CNBC-TV18 brings you a brand new week of Bull's Eye. It's the popular game show where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Buy Cipla, says Abhijit Paul, Brics Securities.
Buy Cipla around Rs 334, says Hemen Kapadia, chartpundit.com.
On CNBC-TV18's new show Super Six, market gurus Hemen Kapadia of chartpundit.com, Hemant Thukral of SBI Capital Securities and Arunesh Madan of Augment Investment, place their bets on two stocks each, thus offering investors a variety of options to choose from.
Buy Cipla with target of Rs 360, says VVLN Sastry, Firstcall India Equity.
Enter Sun Pharma, says Shardul Kulkarni, Sr Technical Analyst, Angel Broking.
Rahul Mohinder, Technical Analyst at viratechindia.com advised going long on Cipla for a target of Rs 350.
On CNBC-TV18's new show Super Six, market gurus chartpundit.com's Hemen Kapadia, technical analyst at viratechindia.com Rahul Mohinder and Angel Broking's Shardul Kulkarni, place their bets on two stocks each.
Buy Cipla with stop loss of Rs 325-330, says Shardul Kulkarni, Angel Broking.
Pharma stocks to outperform, says Prakash Diwan, Head-Institutional Business, Networth Stock Broking.
Sun Pharma can rally upto Rs 512, says Salil Sharma, Kapur Sharma & Co. Salil Sahram Polycom.
Shardul Kulkarni of Angel Broking is of the view that investors should buy Cipla.
Shardul Kulkarni of Angel Broking advised accumulating Cipla at current levels, with a target of Rs 347-348.
Cipla has target of Rs 334, says Prakash Diwan of Networth Stock Broking.
Cipla can touch Rs 330, says Hemant Thukral, SBI Capital Securities.
Hold Cipla, says Phani Sekhar, Fund Manager, Angel Broking.
Cipla has target of Rs 315, says Gaurang Shah, Geojit BNP Paribas Financial Services.
Cipla may add 3-4% before another correction, says Manish Shah of Fortune Financial Services.